| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Friberg Gregory R | EVP, Chief R&D Officer | C/O BIOMARIN PHARMACEUTICAL INC., 770 LINDARO STREET, SAN RAFAEL | /s/ Tae Sang Yoo, Attorney-in-Fact | 2025-10-02 | 0002038768 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BMRN | Common Stock | Tax liability | -$179K | -3.3K | -7.06% | $54.16 | 43.5K | Sep 30, 2025 | Direct |